Year: 2026
Type: article
Abstract: Nasopharyngeal carcinoma is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiotherapy is the cornerstone of locoregional treatment of non-disseminated disease and, in combination with chemotherapy, improves survival rates. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy, and patients may achieve a long survival time. In these guidelines (updated in 2025), we summarize current evidence and available therapies for the medical management of advanced nasopharyngeal carcinoma.
Institutions: Hospital Clínico Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga, Institut Català d'Oncologia, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Marqués de Valdecilla University Hospital, Hospital Universitario de Toledo, Complexo Hospitalario Universitario A Coruña, Hospital Universitario La Paz, Complejo Hospitalario de Ourense, Hospital Universitari de Girona Doctor Josep Trueta, Navarre Institute of Health Research
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,690
OpenAlex ID: W7129754248